Richard Croarkin

Board Director

Director

US·SEC (Form 4)

Aerie Pharmaceuticals Inc

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 21 Nov 2022 for Aerie Pharmaceuticals INC, €238k. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Richard Croarkin: trading record in brief

Richard Croarkin (board member) discloses dealings in Aerie Pharmaceuticals Inc to SEC (Form 4). Over a trading history stretching from 17 June 2021 to 21 November 2022, the count stands at 3 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The record was last updated on 21 November 2022 with a transaction (€238k) in Aerie Pharmaceuticals Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.